Physician profile
Mohsin Maqbool
NPI 1922212620
$7,701.38
in general payments reported to CMS, 2019-2025
49 companies · $1,460 in 2025
The $1,460 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $555 · 2021: $631 · 2022: $1,257 · 2023: $1,399 · 2024: $1,476 · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,235 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,235.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $818.47 | 2019-2025 | Xywav, Epidiolex |
| Supernus Pharmaceuticals, INC. | $712.50 | 2019-2025 | Qelbree, Qelbree |
| Ucb, INC. | $678.22 | 2020-2025 | Fintepla, Briviact |
| Corium, LLC | $676.63 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $591.25 | 2019-2023 | Jornay Pm |
| Livanova USA, INC. | $499.71 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $351.61 | 2021-2025 | Valtoco |
| Harmony Biosciences LLC | $290.78 | 2020-2024 | |
| Immedica Pharma US, INC. | $272.41 | 2022-2024 | |
| Eisai INC. | $232.51 | 2019-2023 | |
| Acadia Pharmaceuticals INC | $199.84 | 2023-2025 | Daybue |
| Sunovion Pharmaceuticals INC. | $189.63 | 2019-2022 | |
| Tris Pharma INC | $172.08 | 2019-2022 | |
| Neos Therapeutics, Lp | $151.59 | 2019-2024 | Adzenys Xr-Odt |
| Upsher-Smith Laboratories LLC | $146.12 | 2019-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsin Maqbool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.